Heterogeneity among melanoma databases and challenges in sustainability: A survey of the Melanoma Prevention Working Group.
作者信息
Mesgarzadeh Sheyda, Myrdal Caitlyn N, Gong Amanda H, Stratton Delaney B, Kelly Brenna G, Curiel-Lewandrowski Clara
机构信息
Division of Dermatology, Department of Medicine, University of Arizona College of Medicine-Tucson, Tucson, Arizona.
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
JAAD Int. 2024 Feb 9;18:137-139. doi: 10.1016/j.jdin.2024.02.001. eCollection 2025 Feb.
Abstract
摘要
相似文献
1
Heterogeneity among melanoma databases and challenges in sustainability: A survey of the Melanoma Prevention Working Group.
JAAD Int. 2024 Feb 9;18:137-139. doi: 10.1016/j.jdin.2024.02.001. eCollection 2025 Feb.
2
Determining the Content of a Melanoma Prevention and Care Mobile Application for Melanoma Patients: A Survey Study.
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):409-418. doi: 10.31557/APJCP.2024.25.2.409.
3
Prevention and screening of melanoma in Europe: 20 years of the Euromelanoma campaign.
J Eur Acad Dermatol Venereol. 2022 Jun;36 Suppl 6:5-11. doi: 10.1111/jdv.18195.
4
Priorities and challenges for skin cancer prevention in Europe: an expert survey.
Melanoma Res. 2013 Aug;23(4):298-306. doi: 10.1097/CMR.0b013e3283632c67.
5
Melanoma of the Skin in the Danish Cancer Registry and the Danish Melanoma Database: A Validation Study.
Epidemiology. 2018 May;29(3):442-447. doi: 10.1097/EDE.0000000000000802.
6
The heterogeneity of population with high risk for melanoma and other skin cancer: a latent class analysis.
Eur J Cancer Prev. 2022 Mar 1;31(2):190-197. doi: 10.1097/CEJ.0000000000000679.
7
Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review.
J Am Acad Dermatol. 2017 Jan;76(1):129-139.e10. doi: 10.1016/j.jaad.2016.07.045. Epub 2016 Oct 1.
8
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.
Genes (Basel). 2021 Jul 19;12(7):1093. doi: 10.3390/genes12071093.
9
The accuracy of artificial intelligence used for non-melanoma skin cancer diagnoses: a meta-analysis.
BMC Med Inform Decis Mak. 2023 Jul 28;23(1):138. doi: 10.1186/s12911-023-02229-w.
10
[Updates on prevention and treatment of melanoma: Pharmacist involvements and challenges].
Ann Pharm Fr. 2016 Sep;74(5):335-49. doi: 10.1016/j.pharma.2016.01.002. Epub 2016 Mar 8.
本文引用的文献
1
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper.
BMJ Open. 2022 Sep 2;12(9):e062139. doi: 10.1136/bmjopen-2022-062139.
2
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Ability to Predict Melanoma Within 5 Years Using Registry Data and a Convolutional Neural Network: A Proof of Concept Study.
Acta Derm Venereol. 2022 Jul 13;102:adv00750. doi: 10.2340/actadv.v102.2028.
4
Computer database for melanoma registry. A clinical management and research tool to monitor outcomes and ensure continuous quality improvement.
Surg Clin North Am. 1996 Dec;76(6):1273-85. doi: 10.1016/s0039-6109(05)70514-4.
Zotero 插件